United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$41Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $7.4M sold, first sale May 2015
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Oct 2013
New Science Venture
Venture Investors
Early Stage Partners
Triathlon Medical Venture Partners
Fletcher Spaght, Inc.Reported by finsmes.comSEC filing: $22M sold, first sale Sept 2008
From the SEC filings it signed: 2 on the team.
On the board, as filediGeorge AridaJack MinerJames BolandLinda TuftsRoger NewtonSuzette Dutch
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Juventas Therapeutics's investors include JumpStart, North Coast Angel Fund, New Science Venture, Venture Investors and Early Stage Partners, and 6 more on record.
Juventas Therapeutics has raised $41M across 4 rounds since 2008.
Juventas Therapeutics's most recent round was a Series B of $14M in May 2015.
Juventas Therapeutics's largest round on record is $22M (Series B), in Jul 2012.
Juventas Therapeutics's first round on record, in Sept 2008, was backed by JumpStart.
Juventas Therapeutics's latest named round is a Series B, in May 2015.
Juventas Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
